Nicorandil

Nicorandil is an orally efficacious vasodilatory drug and antianginal agent marketed in the UK, Australia, most of Europe, India, Philippines, Japan, South Korea, and Taiwan. It is not an approved drug by FDA. It is a niacinamide derivative that induces vasodilation of arterioles and large coronary arteries by activating potassium channels. It is often used for patients with angina who remain symptomatic despite optimal treatment with other antianginal drugs. Nicorandil is a dual-action potassium channel opener that relaxes vascular smooth muscle through membrane hyperpolarization via increased transmembrane potassium conductance and increased intracellular concentration of cyclic GMP. It is shown to dilate normal and stenotic coronary arteries and reduces both ventricular preload and afterload. It is grouped under the following drug class(es): Antianginals, Nitrates and Vasodilating agents. Its therapeutic use is listed as angina. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 2-Nicotinamidoethyl nitrate, Sigmart and Dancor. Its PubChem CID is 47528.

CAS No 65141-46-0
Molecular Formula C8H9N3O4
Molecular Weight 211.17 g/mol
Synonyms 2-(pyridine-3-carbonylamino)ethyl nitrate

Frequently Asked Questions